Translational Life Sciences Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Translational Life Sciences General Information

Description

Developer of proprietary formulations that contain restricted substances such as psilocybin and cannabis to serve unmet medical needs in the market. The company offers research services to treat opioid dependence, psychotic illness, pain management as well as traumatic brain injuries such as concussions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Vancouver, British Columbia
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Cube Psytech
Vertical(s)
Cannabis
Corporate Office
  • Vancouver, British Columbia
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Translational Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Translational Life Sciences‘s full profile, request access.

Request a free trial

Translational Life Sciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Translational Life Sciences‘s full profile, request access.

Request a free trial

Translational Life Sciences FAQs

  • Where is Translational Life Sciences headquartered?

    Translational Life Sciences is headquartered in Vancouver, Canada.

  • What industry is Translational Life Sciences in?

    Translational Life Sciences’s primary industry is Drug Discovery.

  • Is Translational Life Sciences a private or public company?

    Translational Life Sciences is a Private company.

  • What is Translational Life Sciences’s current revenue?

    The current revenue for Translational Life Sciences is .

  • How much funding has Translational Life Sciences raised over time?

    Translational Life Sciences has raised $572K.

  • Who are Translational Life Sciences’s investors?

    NeonMind Biosciences has invested in Translational Life Sciences.

  • When was Translational Life Sciences acquired?

    Translational Life Sciences was acquired on 11-Feb-2023.

  • Who acquired Translational Life Sciences?

    Translational Life Sciences was acquired by Cube Psytech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »